Connect with us

Targeting HER2: Updates on New and Emerging Treatment Approaches in Biliary Tract Cancers and Gastroesophageal Adenocarcinoma for the Community Oncologist

Webinar/Online

Tuesday, November 5, 2024 at 7:00pm CT - 8:00pm CT
This event has ended.

CME

Info

Topic

Gastric Cancers

Credits Offered

This event offers 1.0 CME credit to attendees.
Accreditation Info: Accreditation Council for Continuing Medical Education.

Additional Information

Join us for this great CME talk.

Learning Objectives:

  • Summarize current data informing HER2 expression assessment in GEA and BTC for HER2
  • Analyze the basis for guideline recommendations including diagnostic criteria in the management of HER2-positive GEA and BTC
  • Evaluate clinical trial findings involving treatments targeting HER2 in GEA and BTC in the second-line treatment setting and differentiate those treatment options

Speakers

Thomas H. Cartwright
Thomas H. Cartwright MD

Associate Professor

Dr. Thomas Cartwright is an Associate Professor of Medicine at the University of Central Florida School of Medicine in Ocala, FL.

Event Agenda

Targeting HER2: Updates on New and Emerging Treatment Approaches in Biliary Tract Cancers and Gastroesophageal Adenocarcinoma for the Community Oncologist

Event Agenda

Tuesday, November 5, 2024 at 7:00pm CT - 8:00pm CT

All times listed in Central Time (US & Canada).
Download event agenda (PDF)

Tuesday, November 5, 2024

  • 7:00pm - 8:00pm

    Targeting HER2: Updates on New and Emerging Treatment Approaches in Biliary Tract Cancers and Gastroesophageal Adenocarcinoma for the Community Oncologist

    Thomas H. Cartwright, MD
    1.0 CE Credit

    Learning Objectives:
    - Summarize current data informing HER2 expression assessment in GEA and BTC for HER2
    - Analyze the basis for guideline recommendations including diagnostic criteria in the management of HER2-positive GEA and BTC
    - Evaluate clinical trial findings involving treatments targeting HER2 in GEA and BTC in the second-line treatment setting and differentiate those treatment options